Supplemental magnesium gluconate recovers osteoblastic Wntless ablation-induced degenerative bone complications
- 4 April 2025
- journal article
- research article
- Published by Springer Nature in Journal of Bone and Mineral Metabolism
- Vol. 43 (4) , 319-334
Abstract
Introduction Although numerous studies have highlighted the involvement of Wnt-mediated signaling in Mg ion-enhanced bone healing, whether Wnt-stimulated signaling is essential for the Mg ion-triggered bone repair and mass accrual is not yet completely understood. Materials and methods We generated Wlsfl/fl wild-type (WT) control and their corresponding mutant (MT), Col2.3-Cre;Wlsfl/fl mice of osteoblastic Wntless (Wls) ablation and explored how supplemental magnesium gluconate (MgG) affects bone mass accrual and defected bone healing in relation to the Wls ablation. Results Osteoblastic Wls ablation impaired bone mass accrual and bone healing along with age-related degenerative complications in bone marrow (BM) and BM cells. Oral supplementation of WT mice with MgG did not change natural bone mass accrual, but enhanced regenerative bone healing in femoral defects and the functionalities of BM cells. Supplemental MgG suppressed the Wls ablation-related bone loss and also stimulated new bone formation in the defects of MT mice. The MgG-induced beneficial effects in the MT mice were orchestrated with its potencies to ameliorate senescence, oxidative damage, and functional loss of BM and BM adherent cells, as well as to stimulate osteogenic activity. Conclusion This study demonstrates that supplemental MgG is able to improve bone homeostatic maintenance by recovering age-related degenerative complications even at the lack of osteoblastic Wnt-stimulated signaling.Keywords
Funding Information
- Ministry of Education, Science and Technology (RS-2024-00338143, RS-2023-00269830, 2021R1A2C2006032)
This publication has 41 references indexed in Scilit:
- Bone Cell Senescence: Mechanisms and PerspectivesJournal of Bone and Mineral Research, 2014
- Osteoblastic Wnts differentially regulate bone remodeling and the maintenance of bone marrow mesenchymal stem cellsBone, 2013
- WNT signaling in bone homeostasis and disease: from human mutations to treatmentsNature Medicine, 2013
- Wntless functions in mature osteoblasts to regulate bone massProceedings of the National Academy of Sciences, 2012
- Ectopic Expression of Col2.3 and Col3.6 Promoters in the Brain and Association with Leptin SignalingCells Tissues Organs, 2011
- Canonical Wnts function as potent regulators of osteogenesis by human mesenchymal stem cellsJournal of Cell Biology, 2009
- Age‐related intrinsic changes in human bone‐marrow‐derived mesenchymal stem cells and their differentiation to osteoblastsAging Cell, 2008
- Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cellsNature Medicine, 2006
- Expression and activity of osteoblast-targeted Cre recombinase transgenes in murine skeletal tissuesThe International Journal of Developmental Biology, 2004
- Tie2/Angiopoietin-1 Signaling Regulates Hematopoietic Stem Cell Quiescence in the Bone Marrow NicheCell, 2004